1. The pathogenesis and development of targeted drugs in acute T lymphoblastic leukaemia
   Zhaoying Chen et al, 2023, British Journal of Pharmacology CrossRef
2. The Clinical Characteristics and Prognosis of AYA and Older Adult ETP-ALL/LBL: A Real-World Multicenter Study in China
   Jinyan Xiao et al, 2022, Frontiers in Oncology CrossRef
3. The Role of Genetics and Synergistic Effect of Targeting Common Genetic Mutations in Acute Lymphoblastic Leukemia (ALL)
   Niloofar Pilehvari et al, 2023, Mini-Reviews in Medicinal Chemistry CrossRef
4. The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia
   Francesca Gianni et al, 2020, Cold Spring Harbor Perspectives in Medicine CrossRef
5. Case Report: The First Report of NUP214-ABL1 Fusion Gene in Acute Myeloid Leukemia Patient Detected by Next-Generation Sequencing
   Huan-Ping Wang et al, 2021, Frontiers in Oncology CrossRef
6. Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene Fusion
   Egle Stukaite-Ruibiene et al, 2022, Pathology and Oncology Research CrossRef
7. Detection of a cryptic NUP214/ABL1 gene fusion by mate-pair sequencing (MPseq) in a newly diagnosed case of pediatric T-lymphoblastic leukemia
   Jess F. Peterson et al, 2019, Molecular Case Studies CrossRef
8. A Comparative Analysis of Early T-Cell Precursor Lymphoblastic Leukemia/Lymphoma (ETP-ALL/LBL) and Non-ETP-ALL/LBL in a Tertiary Cancer Care Center Based in Western India
   Anurag Saha et al, 2023, Indian Journal of Hematology and Blood Transfusion CrossRef